$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
凡德他尼纳入医保了吗?多少钱一盒?
2025-10-19 11:44:20
Check Details
首个获批治疗甲状腺髓样癌的药物-凡德他尼
2025-10-19 11:44:20
Check Details
甲状腺髓样癌患者吃凡德他尼大概多长时间会产生耐药性?
2025-10-19 11:44:20
Check Details
凡德他尼治疗甲状腺癌的作用靶点
2025-10-19 11:44:20
Check Details
凡德他尼治疗进展期遗传性甲状腺髓样癌的疗效和毒副作用
2025-10-19 11:44:20
Check Details
患者须知:甲状腺癌患者服用凡德他尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
凡德他尼在国内的购买途径及价格
2025-10-19 11:44:20
Check Details
多吉美治疗分化型甲状腺癌的分析
2025-10-19 11:44:20
Check Details
甲状腺癌患者吃多吉美多久才可以停药?
2025-10-19 11:44:20
Check Details
FDA批准多吉美用于晚期分化型甲状腺癌
2025-10-19 11:44:20
Check Details
多吉美对分化型甲状腺癌有效果吗?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET融合阳性甲状腺癌的疗效分析
2025-10-19 11:44:20
Check Details
1
2
...
2534
2535
2536
2537
2538
2539
2540
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
2
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
3
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
4
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
5
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
6
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
7
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
8
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
9
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
10
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
11
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
12
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained